Ciprofloxacin vs an Aminoglycoside in Combination With a β-Lactam for the Treatment of Febrile Neutropenia: A Meta-analysis of Randomized Controlled Trials

Klastersky, 1988, Empirical antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials, Recent Results Cancer Res, 108, 53, 10.1007/978-3-642-82932-1_8 Rhomberg, 2004, Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003), Diagn Microbiol Infect Dis, 49, 273, 10.1016/j.diagmicrobio.2004.02.003 Kiffer, 2004, Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002, Diagn Microbiol Infect Dis, 49, 109, 10.1016/j.diagmicrobio.2004.03.003 Cabezudo, 1990, In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolates, Am J Infect Control, 18, 250, 10.1016/0196-6553(90)90166-P Jenkins, 1989, Activity of cefotaxime/desacetylcefotaxime with two aminoglycosides against gram-negative pathogens: an example of interactive synergy, Diagn Microbiol Infect Dis, 12, 51, 10.1016/0732-8893(89)90046-1 Whiting, 1987, Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria, Antimicrob Agents Chemother, 31, 1379, 10.1128/AAC.31.9.1379 Bustamante, 1990, In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa, Antimicrob Agents Chemother, 34, 1814, 10.1128/AAC.34.9.1814 Aubert, 1991, In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci [in French], Pathol Biol (Paris), 39, 1006 Oken, 1982, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014 Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Lau, 1997, Quantitative synthesis in systematic reviews, Ann Intern Med, 127, 820, 10.7326/0003-4819-127-9-199711010-00008 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Mantel, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Chan, 1989, Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients, Antimicrob Agents Chemother, 33, 87, 10.1128/AAC.33.1.87 Flaherty, 1989, Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients, Am J Med, 87, 278S, 10.1016/0002-9343(89)90080-6 Giamarellou, 2000, Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever, Antimicrob Agents Chemother, 44, 3264, 10.1128/AAC.44.12.3264-3271.2000 Glauser, 2002, Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients, Clin Microbiol Infect, 8, 14, 10.1046/j.1198-743x.2001.00338.x Griggs, 1998, Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy, Am J Hematol, 58, 293, 10.1002/(SICI)1096-8652(199808)58:4<293::AID-AJH7>3.0.CO;2-L Hidalgo, 1999, Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial, Cancer, 85, 213, 10.1002/(SICI)1097-0142(19990101)85:1<213::AID-CNCR29>3.3.CO;2-4 Hyatt, 1991, A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients [letter], J Antimicrob Chemother, 28, 324, 10.1093/jac/28.2.324 Johnson, 1992, A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients, J Antimicrob Chemother, 30, 203, 10.1093/jac/30.2.203 Kelsey, 1990, A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients, J Antimicrob Chemother, 25, 149, 10.1093/jac/25.1.149 Kelsey, 1990, A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients, Br J Haematol, 76, 10, 10.1111/j.1365-2141.1990.tb07928.x Kern, 1999, Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy, N Engl J Med, 341, 312, 10.1056/NEJM199907293410502 Krcmery, 1992, Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters: short communication, Chemotherapy, 38, 271, 10.1159/000239011 Madiajagane, 1993, Antibiotics in febrile neutropenia: a randomized prospective comparison of two combinations, Natl Med J India, 6, 67 Maiche, 1991, Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations, Infection, 19, S326, 10.1007/BF01715773 Malik, 1992, Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients [published correction appears in Lancet. 1992;340:128], Lancet, 339, 1092, 10.1016/0140-6736(92)90674-R Meunier, 1991, Antimicrob Agents Chemother, 35, 873, 10.1128/AAC.35.5.873 Nenova, 2003, Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies, Folia Med (Plovdiv), 45, 13 Paganini, 2001, Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia, Cancer, 91, 1563, 10.1002/1097-0142(20010415)91:8<1563::AID-CNCR1166>3.0.CO;2-C Paganini, 2003, Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina, Cancer, 97, 1775, 10.1002/cncr.11251 Peacock, 2002, Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients: a randomized, double-blind trial, Ann Intern Med, 137, 77, 10.7326/0003-4819-137-2-200207160-00005 Philpott-Howard, 1990, Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients, J Antimicrob Chemother, 26, 89, 10.1093/jac/26.suppl_F.89 Velasco, 1995, Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients, Am J Clin Oncol, 18, 429, 10.1097/00000421-199510000-00014 Anaissie, 1997, Therapy for low-risk cancer patients with fever and neutropenia: results of a prospective, randomized trial with cost analysis [abstract], Abstr Intersci Conf Antimicrob Agents Chemother, 37, 373 Hughes, 2002, 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer, Clin Infect Dis, 34, 730, 10.1086/339215 Link, 2003, Ann Hematol, 82, S105, 10.1007/s00277-003-0764-4